AMGN.NASDAQAmgen INC

Form 4: Amgen SVP Rachna Khosla Reports Stock Transaction

Sentiment:

SEC Form 4 Filing


Rachna Khosla, SVP of Business Development at Amgen, reports the disposition of 212 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

  • On November 5, 2024, Rachna Khosla, SVP of Business Development at Amgen, filed a Form 4 indicating a transaction involving Amgen's common stock.
  • The transaction involved the disposition of 212 shares at a price of $316.91 per share.
  • This disposition was related to covering tax obligations associated with the vesting of Restricted Stock Units (RSUs).
  • Following the transaction, Khosla directly owns 8,383 shares of Amgen common stock, which includes unvested RSUs and dividend equivalents.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and the transaction is related to tax obligations, so the sentiment is neutral.

Industry Context

Form 4 filings are routine disclosures required by the SEC for corporate insiders, providing transparency into their trading activities and ownership positions in the company's stock.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a routine sale of shares to cover tax obligations.

Key Dates

DateDescription
11/05/2024Date of stock transaction and Form 4 filing.
4/30/2025Vesting date for 128 RSUs.
11/5/2025Vesting date for 398 RSUs.
5/2/2025Vesting date for 200 RSUs.
5/2/2026Vesting date for 207 RSUs.
5/2/2025Vesting date for 195 RSUs.
5/2/2026Vesting date for 196 RSUs.
5/2/2027Vesting date for 202 RSUs.
5/7/2026Vesting date for 175 RSUs.
5/7/2027Vesting date for 176 RSUs.
5/7/2028Vesting date for 181 RSUs.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.